Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma

• Published in: The European respiratory journal Vol. 59; no. 4; p. 2100768
• Main Authors: Busby, John, Matthews, John G., Chaudhuri, Rekha, Pavord, Ian D., Hardman, Timothy C., Arron, Joseph R., Bradding, Peter, Brightling, Christopher E., Choy, David F., Cowan, Douglas C., Djukanovic, Ratko, Hanratty, Catherine E., Harrison, Tim W., Holweg, Cecile T., Howarth, Peter H., Fowler, Stephen J., Lordan, James L., Mansur, Adel H., Menzies-Gow, Andrew, Niven, Robert M., Robinson, Douglas S., Walker, Samantha M., Woodcock, Ashley, Heaney, Liam G.
• Format: Journal Article
• Language: English
• Published: England European Respiratory Society 01.04.2022
• Subjects: Adrenal Cortex Hormones - therapeutic use; Asthma - drug therapy; Ethnicity; Humans; Minority Groups; Original s; Single-Blind Method
• ISSN: 0903-1936; 1399-3003; 1399-3003
• DOI: 10.1183/13993003.00768-2021

Understanding why patients with severe asthma do not follow healthcare provider (HCP) advice to adjust treatment is critical to achieving personalised disease management. We reviewed patient choice to follow HCP advice to adjust asthma treatment in a UK-based randomised, controlled, single-blind (study participant), multicentre, parallel group 48-week clinical study comparing biomarker-directed treatment adjustment with standard care in severe asthma. Of 1572 treatment advisories (291 participants), instructions were followed in 1377 cases (87.6%). Patients were more likely to follow advice to remain on treatment (96.7%) than to either reduce (70.3%) or increase (67.1%) their treatment, with 64% of patients following all treatment advice. Multivariate analysis associated belonging to an ethnic minority group (OR 3.10, 95% CI 1.68-5.73) and prior study medication changes (two or more changes: OR 2.77, 95% CI 1.51-5.10) with failure to follow treatment advice. In contrast, emergency room attendance in the prior year (OR 0.54, 95% CI 0.32-0.92) was associated with following treatment advice. The largest effect was seen with transition onto or off oral corticosteroids (OR 29.28, 95% CI 16.07-53.36) when compared with those requested to maintain treatment. Centre was also an important determinant regarding the likelihood of patients to follow treatment advice. Belonging to an ethnic minority group and multiple prior treatment adjustments were associated with not following HCP treatment advice. Patients also responded differently to HCP advice across UK specialist centres. These findings have implications for the generalisability of models of care in severe asthma and require further focused studies.